Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes - from the ESC-HFA EORP Heart Failure Long-Term Registry.


Journal

European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595

Informations de publication

Date de publication:
09 2023
Historique:
revised: 29 03 2023
received: 27 12 2022
accepted: 23 04 2023
medline: 23 10 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: ppublish

Résumé

To comprehensively assess hyponatraemia in acute heart failure (AHF) regarding prevalence, associations, hospital course, and post-discharge outcomes. Of 8298 patients in the European Society of Cardiology Heart Failure Long-Term Registry hospitalized for AHF with any ejection fraction, 20% presented with hyponatraemia (serum sodium <135 mmol/L). Independent predictors included lower systolic blood pressure, estimated glomerular filtration rate (eGFR) and haemoglobin, along with diabetes, hepatic disease, use of thiazide diuretics, mineralocorticoid receptor antagonists, digoxin, higher doses of loop diuretics, and non-use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and beta-blockers. In-hospital death occurred in 3.3%. The prevalence of hyponatraemia and in-hospital mortality with different combinations were: 9% hyponatraemia both at admission and discharge (hyponatraemia Yes/Yes, in-hospital mortality 6.9%), 11% Yes/No (in-hospital mortality 4.9%), 8% No/Yes (in-hospital mortality 4.7%), and 72% No/No (in-hospital mortality 2.4%). Correction of hyponatraemia was associated with improvement in eGFR. In-hospital development of hyponatraemia was associated with greater diuretic use and worsening eGFR but also more effective decongestion. Among hospital survivors, 12-month mortality was 19% and adjusted hazard ratios (95% confidence intervals) were for hyponatraemia Yes/Yes 1.60 (1.35-1.89), Yes/No 1.35 (1.14-1.59), and No/Yes 1.18 (0.96-1.45). For death or heart failure hospitalization they were 1.38 (1.21-1.58), 1.17 (1.02-1.33), and 1.09 (0.93-1.27), respectively. Among patients with AHF, 20% had hyponatraemia at admission, which was associated with more advanced heart failure and normalized in half of patients during hospitalization. Admission hyponatraemia (possibly dilutional), especially if it did not resolve, was associated with worse in-hospital and post-discharge outcomes. Hyponatraemia developing during hospitalization (possibly depletional) was associated with lower risk.

Identifiants

pubmed: 37114294
doi: 10.1002/ejhf.2873
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1571-1583

Investigateurs

Christopher Peter Gale (CP)
Branko Beleslin (B)
Andrzej Budaj (A)
Ovidiu Chioncel (O)
Nikolaos Dagres (N)
Nicolas Danchin (N)
David Erlinge (D)
Jonathan Emberson (J)
Michael Glikson (M)
Alastair Gray (A)
Meral Kayikcioglu (M)
Aldo Maggioni (A)
Klaudia Vivien Nagy (KV)
Aleksandr Nedoshivin (A)
Anna-Sonia Petronio (AS)
Jolien Roos-Hesselink (J)
Lars Wallentin (L)
Uwe Zeymer (U)
M Crespo-Leiro (M)
S Anker (S)
A Mebazaa (A)
A Coats (A)
G Filippatos (G)
R Ferrari (R)
A P Maggioni (AP)
M F Piepoli (MF)
A Goda (A)
M Diez (M)
A Fernandez (A)
F Fruhwald (F)
E Fazlibegovic (E)
P Gatzov (P)
A Kurlianskaya (A)
R Hullin (R)
T Christodoulides (T)
J Hradec (J)
O Wendelboe Nielsen (OW)
R Nedjar (R)
T Uuetoa (T)
M Hassanein (M)
J F Delgado Jimenez (JFD)
V-P Harjola (VP)
D Logeart (D)
V Chumburidze (V)
D Tousoulis (D)
D Milicic (D)
B Merkely (B)
E O'Donoghue (E)
O Amir (O)
A Shotan (A)
D Shafie (D)
M Metra (M)
A Matsumori (A)
E Mirrakhimov (E)
A Kavoliuniene (A)
A Erglis (A)
E Vataman (E)
M Otljanska (M)
E Srbinovska Kostovska (ES)
D Cassar DeMarco (DC)
J Drozdz (J)
C Fonseca (C)
O Chioncel (O)
M Dekleva (M)
E Shkolnik (E)
U Dahlstrom (U)
M Lainscak (M)
E Goncalvesova (E)
A Temizhan (A)
V Estrago (V)
G Bajraktari (G)
J Auer (J)
K Ablasser (K)
F Fruhwald (F)
T Dolze (T)
K Brandner (K)
S Gstrein (S)
G Poelzl (G)
D Moertl (D)
S Reiter (S)
A Podczeck-Schweighofer (A)
A Muslibegovic (A)
M Vasilj (M)
E Fazlibegovic (E)
M Cesko (M)
D Zelenika (D)
B Palic (B)
D Pravdic (D)
D Cuk (D)
K Vitlianova (K)
T Katova (T)
T Velikov (T)
T Kurteva (T)
P Gatzov (P)
D Kamenova (D)
M Antova (M)
V Sirakova (V)
J Krejci (J)
M Mikolaskova (M)
J Spinar (J)
J Krupicka (J)
F Malek (F)
M Hegarova (M)
M Lazarova (M)
Z Monhart (Z)
M Hassanein (M)
M Sobhy (M)
F El Messiry (F)
A H El Shazly (AH)
Y Elrakshy (Y)
A Youssef (A)
A A Moneim (AA)
M Noamany (M)
A Reda (A)
T K Abdel Dayem (TKA)
N Farag (N)
S Ibrahim Halawa (SI)
M Abdel Hamid (MA)
K Said (K)
A Saleh (A)
H Ebeid (H)
R Hanna (R)
R Aziz (R)
O Louis (O)
M A Enen (MA)
B S Ibrahim (BS)
G Nasr (G)
A Elbahry (A)
H Sobhy (H)
M Ashmawy (M)
M Gouda (M)
W Aboleineen (W)
Y Bernard (Y)
P Luporsi (P)
N Meneveau (N)
M Pillot (M)
M Morel (M)
M-F Seronde (MF)
F Schiele (F)
F Briand (F)
F Delahaye (F)
T Damy (T)
J-C Eicher (JC)
P de Groote (P)
M Fertin (M)
N Lamblin (N)
R Isnard (R)
C Lefol (C)
S Thevenin (S)
A Hagege (A)
G Jondeau (G)
D Logeart (D)
V Le Marcis (V)
J-F Ly (JF)
D Coisne (D)
B Lequeux (B)
V Le Moal (V)
S Mascle (S)
P Lotton (P)
N Behar (N)
E Donal (E)
C Thebault (C)
C Ridard (C)
A Reynaud (A)
A Basquin (A)
F Bauer (F)
R Codjia (R)
M Galinier (M)
P Tourikis (P)
M Stavroula (M)
D Tousoulis (D)
C Stefanadis (C)
C Chrysohoou (C)
I Kotrogiannis (I)
V Matzaraki (V)
T Dimitroula (T)
A Karavidas (A)
G Tsitsinakis (G)
C Kapelios (C)
J Nanas (J)
H Kampouri (H)
E Nana (E)
E Kaldara (E)
A Eugenidou (A)
P Vardas (P)
I Saloustros (I)
A Patrianakos (A)
T Tsaknakis (T)
S Evangelou (S)
N Nikoloulis (N)
H Tziourganou (H)
A Tsaroucha (A)
A Papadopoulou (A)
A Douras (A)
L Polgar (L)
B Merkely (B)
A Kosztin (A)
N Nyolczas (N)
A Csaba Nagy (AC)
R Halmosi (R)
J Elber (J)
I Alony (I)
A Shotan (A)
A Vazan Fuhrmann (AV)
O Amir (O)
S Romano (S)
S Marcon (S)
M Penco (M)
M Di Mauro (M)
E Lemme (E)
V Carubelli (V)
R Rovetta (R)
M Metra (M)
M Bulgari (M)
F Quinzani (F)
C Lombardi (C)
S Bosi (S)
G Schiavina (G)
A Squeri (A)
A Barbieri (A)
G Di Tano (G)
S Pirelli (S)
R Ferrari (R)
A Fucili (A)
T Passero (T)
S Musio (S)
M Di Biase (M)
M Correale (M)
G Salvemini (G)
S Brognoli (S)
E Zanelli (E)
A Giordano (A)
P Agostoni (P)
G Italiano (G)
E Salvioni (E)
S Copelli (S)
M G Modena (MG)
L Reggianini (L)
C Valenti (C)
A Olaru (A)
S Bandino (S)
M Deidda (M)
G Mercuro (G)
C Cadeddu Dessalvi (CC)
P N Marino (PN)
M V Di Ruocco (MV)
C Sartori (C)
C Piccinino (C)
G Parrinello (G)
G Licata (G)
D Torres (D)
S Giambanco (S)
S Busalacchi (S)
S Arrotti (S)
S Novo (S)
R M Inciardi (RM)
P Pieri (P)
P R Chirco (PR)
M Ausilia Galifi (MA)
G Teresi (G)
D Buccheri (D)
A Minacapelli (A)
M Veniani (M)
A Frisinghelli (A)
S G Priori (SG)
S Cattaneo (S)
C Opasich (C)
A Gualco (A)
M Pagliaro (M)
M Mancone (M)
F Fedele (F)
A Cinque (A)
M Vellini (M)
I Scarfo (I)
F Romeo (F)
F Ferraiuolo (F)
D Sergi (D)
M Anselmi (M)
F Melandri (F)
E Leci (E)
E Iori (E)
V Bovolo (V)
S Pidello (S)
S Frea (S)
S Bergerone (S)
M Botta (M)
F G Canavosio (FG)
F Gaita (F)
M Merlo (M)
M Cinquetti (M)
G Sinagra (G)
F Ramani (F)
E Fabris (E)
D Stolfo (D)
J Artico (J)
D Miani (D)
C Fresco (C)
C Daneluzzi (C)
A Proclemer (A)
M Cicoira (M)
L Zanolla (L)
G Marchese (G)
F Torelli (F)
C Vassanelli (C)
N Voronina (N)
A Erglis (A)
V Tamakauskas (V)
V Smalinskas (V)
R Karaliute (R)
I Petraskiene (I)
E Kazakauskaite (E)
E Rumbinaite (E)
A Kavoliuniene (A)
V Vysniauskas (V)
R Brazyte-Ramanauskiene (R)
D Petraskiene (D)
S Stankala (S)
P Switala (P)
Z Juszczyk (Z)
W Sinkiewicz (W)
W Gilewski (W)
J Pietrzak (J)
T Orzel (T)
P Kasztelowicz (P)
P Kardaszewicz (P)
M Lazorko-Piega (M)
J Gabryel (J)
K Mosakowska (K)
J Bellwon (J)
A Rynkiewicz (A)
G Raczak (G)
E Lewicka (E)
A Dabrowska-Kugacka (A)
R Bartkowiak (R)
B Sosnowska-Pasiarska (B)
B Wozakowska-Kaplon (B)
A Krzeminski (A)
M Zabojszcz (M)
E Mirek-Bryniarska (E)
A Grzegorzko (A)
K Bury (K)
J Nessler (J)
J Zalewski (J)
A Furman (A)
M Broncel (M)
A Poliwczak (A)
A Bala (A)
P Zycinski (P)
M Rudzinska (M)
L Jankowski (L)
J D Kasprzak (JD)
L Michalak (L)
K Wojtczak Soska (KW)
J Drozdz (J)
I Huziuk (I)
A Retwinski (A)
P Flis (P)
J Weglarz (J)
A Bodys (A)
S Grajek (S)
M Kaluzna-Oleksy (M)
E Straburzynska-Migaj (E)
R Dankowski (R)
K Szymanowska (K)
J Grabia (J)
A Szyszka (A)
A Nowicka (A)
M Samcik (M)
L Wolniewicz (L)
K Baczynska (K)
K Komorowska (K)
I Poprawa (I)
E Komorowska (E)
D Sajnaga (D)
A Zolbach (A)
A Dudzik-Plocica (A)
A-F Abdulkarim (AF)
A Lauko-Rachocka (A)
L Kaminski (L)
A Kostka (A)
A Cichy (A)
P Ruszkowski (P)
M Splawski (M)
G Fitas (G)
A Szymczyk (A)
A Serwicka (A)
A Fiega (A)
D Zysko (D)
W Krysiak (W)
S Szabowski (S)
E Skorek (E)
P Pruszczyk (P)
P Bienias (P)
M Ciurzynski (M)
M Welnicki (M)
A Mamcarz (A)
A Folga (A)
T Zielinski (T)
T Rywik (T)
P Leszek (P)
M Sobieszczanska-Malek (M)
M Piotrowska (M)
K Kozar-Kaminska (K)
K Komuda (K)
J Wisniewska (J)
A Tarnowska (A)
P Balsam (P)
M Marchel (M)
G Opolski (G)
A Kaplon-Cieslicka (A)
R J Gil (RJ)
O Mozenska (O)
K Byczkowska (K)
K Gil (K)
A Pawlak (A)
A Michalek (A)
P Krzesinski (P)
K Piotrowicz (K)
B Uzieblo-Zyczkowska (B)
A Stanczyk (A)
A Skrobowski (A)
P Ponikowski (P)
E Jankowska (E)
P Rozentryt (P)
L Polonski (L)
E Gadula-Gacek (E)
E Nowalany-Kozielska (E)
A Kuczaj (A)
Z Kalarus (Z)
M Szulik (M)
K Przybylska (K)
J Klys (J)
G Prokop-Lewicka (G)
A Kleinrok (A)
C Tavares Aguiar (CT)
A Ventosa (A)
S Pereira (S)
R Faria (R)
J Chin (J)
I De Jesus (I)
R Santos (R)
P Silva (P)
N Moreno (N)
C Queirós (C)
C Lourenço (C)
A Pereira (A)
A Castro (A)
A Andrade (A)
T Oliveira Guimaraes (TO)
S Martins (S)
R Placido (R)
G Lima (G)
D Brito (D)
A R Francisco (AR)
R Cardiga (R)
M Proenca (M)
I Araujo (I)
F Marques (F)
C Fonseca (C)
B Moura (B)
S Leite (S)
M Campelo (M)
J Silva-Cardoso (J)
J Rodrigues (J)
I Rangel (I)
E Martins (E)
A Sofia Correia (AS)
M Peres (M)
L Marta (L)
G Ferreira da Silva (GF)
D Severino (D)
D Durao (D)
S Leao (S)
P Magalhaes (P)
I Moreira (I)
A Filipa Cordeiro (AF)
C Ferreira (C)
C Araujo (C)
A Ferreira (A)
A Baptista (A)
M Radoi (M)
G Bicescu (G)
D Vinereanu (D)
C-J Sinescu (CJ)
C Macarie (C)
R Popescu (R)
I Daha (I)
G-A Dan (GA)
C Stanescu (C)
A Dan (A)
E Craiu (E)
E Nechita (E)
V Aursulesei (V)
R Christodorescu (R)
P Otasevic (P)
P M Seferovic (PM)
D Simeunovic (D)
A D Ristic (AD)
V Celic (V)
M Pavlovic-Kleut (M)
J Suzic Lazic (JS)
B Stojcevski (B)
B Pencic (B)
A Stevanovic (A)
A Andric (A)
Dragan Simić (D)
Milika Ašanin (M)
V Iric-Cupic (V)
M Jovic (M)
G Davidovic (G)
S Milanov (S)
V Mitic (V)
V Atanaskovic (V)
S Antic (S)
M Pavlovic (M)
D Stanojevic (D)
V Stoickov (V)
S Ilic (S)
M Deljanin Ilic (MD)
D Petrovic (D)
S Stojsic (S)
S Kecojevic (S)
S Dodic (S)
N Cemerlic Adic (NC)
M Cankovic (M)
J Stojiljkovic (J)
B Mihajlovic (B)
A Radin (A)
S Radovanovic (S)
M Krotin (M)
A Klabnik (A)
E Goncalvesova (E)
M Pernicky (M)
J Murin (J)
F Kovar (F)
J Kmec (J)
H Semjanova (H)
M Strasek (M)
M Savnik Iskra (MS)
T Ravnikar (T)
N Cernic Suligoj (NC)
J Komel (J)
Z Fras (Z)
B Jug (B)
T Glavic (T)
R Losic (R)
M Bombek (M)
I Krajnc (I)
B Krunic (B)
S Horvat (S)
D Kovac (D)
D Rajtman (D)
V Cencic (V)
M Letonja (M)
R Winkler (R)
M Valentincic (M)
C Melihen-Bartolic (C)
A Bartolic (A)
M Pusnik Vrckovnik (MP)
M Kladnik (M)
C Slemenik Pusnik (CS)
A Marolt (A)
J Klen (J)
B Drnovsek (B)
B Leskovar (B)
M J Fernandez Anguita (MJF)
J C Gallego Page (JCG)
F M Salmeron Martinez (FMS)
J Andres (J)
A B Genis (AB)
S Mirabet (S)
A Mendez (A)
L Garcia-Cosio (L)
E Roig (E)
V Leon (V)
J Gonzalez-Costello (J)
G Muntane (G)
A Garay (A)
V Alcade-Martinez (V)
S Lopez Fernandez (SL)
R Rivera-Lopez (R)
M Puga-Martinez (M)
M Fernandez-Alvarez (M)
J L Serrano-Martinez (JL)
M Crespo-Leiro (M)
Z Grille-Cancela (Z)
R Marzoa-Rivas (R)
P Blanco-Canosa (P)
M J Paniagua-Martin (MJ)
E Barge-Caballero (E)
I Laynez Cerdena (IL)
I Famara Hernandez Baldomero (IFH)
A Lara Padron (AL)
S Ofelia Rosillo (SO)
R Dalmau Gonzalez-Gallarza (RD)
O Salvador Montanes (OS)
A M Iniesta Manjavacas (AMI)
A Castro Conde (AC)
A Araujo (A)
T Soria (T)
P Garcia-Pavia (P)
M Gomez-Bueno (M)
M Cobo-Marcos (M)
L Alonso-Pulpon (L)
J Segovia Cubero (JS)
I Sayago (I)
A Gonzalez-Segovia (A)
A Briceno (A)
P Escribano Subias (PE)
M Vicente Hernandez (MV)
M J Ruiz Cano (MJR)
M A Gomez Sanchez (MAG)
J F Delgado Jimenez (JFD)
E Barrios Garrido-Lestache (EB)
J M Garcia Pinilla (JMG)
B Garcia de la Villa (BG)
A Sahuquillo (A)
R Bravo Marques (RB)
F Torres Calvo (FT)
M T Perez-Martinez (MT)
M R Gracia-Rodenas (MR)
I P Garrido-Bravo (IP)
F Pastor-Perez (F)
D A Pascual-Figal (DA)
B Diaz Molina (BD)
J Orus (J)
F Epelde Gonzalo (FE)
V Bertomeu (V)
R Valero (R)
R Martinez-Abellan (R)
J Quiles (J)
J A Rodrigez-Ortega (JA)
I Mateo (I)
A ElAmrani (A)
C Fernandez-Vivancos (C)
D Bierge Valero (DB)
L Almenar-Bonet (L)
I J Sanchez-Lazaro (IJ)
E Marques-Sule (E)
L Facila-Rubio (L)
J Perez-Silvestre (J)
P Garcia-Gonzalez (P)
F Ridocci-Soriano (F)
D Garcia-Escriva (D)
A Pellicer-Cabo (A)
L de la Fuente Galan (L)
J Lopez Diaz (JL)
A Recio Platero (AR)
J C Arias (JC)
T Blasco-Peiro (T)
M Sanz Julve (MS)
E Sanchez-Insa (E)
C Aured-Guallar (C)
A Portoles-Ocampo (A)
M Melin (M)
E Hägglund (E)
A Stenberg (A)
I-M Lindahl (IM)
B Asserlund (B)
L Olsson (L)
U Dahlström (U)
M Afzelius (M)
P Karlström (P)
L Tengvall (L)
P-A Wiklund (PA)
B Olsson (B)
S Kalayci (S)
A Temizhan (A)
Y Cavusoglu (Y)
E Gencer (E)
M B Yilmaz (MB)
H Gunes (H)

Informations de copyright

© 2023 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Gheorghiade M, Abraham WT, Albert NM, Gattis Stough W, Greenberg BH, O'Connor CM, et al.; OPTIMIZE-HF Investigators and Coordinators. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J. 2007;28:980-8.
Sato N, Gheorghiade M, Kajimoto K, Munakata R, Minami Y, Mizuno M, et al.; ATTEND Investigators. Hyponatraemia and in-hospital mortality in patients admitted for heart failure (from the ATTEND registry). Am J Cardiol. 2013;111:1019-25.
Rossi J, Bayram M, Udelson JE, Lloyd-Jones D, Adams KF, Oconnor CM, et al. Improvement in hyponatraemia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial. Acute Card Care. 2007;9:82-6.
Kapłon-Cieślicka A, Ozierański K, Balsam P, Tymińska A, Peller M, Galas M, et al. Clinical characteristics and 1-year outcome of hyponatremic patients hospitalized for heart failure. Pol Arch Med Wewn. 2015;125:120-31.
Kapłon-Cieślicka A, Soloveva A, Mareev Y, Cabac-Pogorevici I, Verbrugge FH, Vardas P. Hyponatraemia in heart failure: time for new solutions? Heart. 2022;108:1179-85.
Hauptman PJ, Burnett J, Gheorghiade M, Grinfeld L, Konstam MA, Kostic D, et al.; Everest Investigators. Clinical course of patients with hyponatraemia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan. J Card Fail. 2013;19:390-7.
Bavishi C, Ather S, Bambhroliya A, Jneid H, Virani SS, Bozkurt B, et al. Prognostic significance of hyponatraemia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol. 2014;113:1834-8.
Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424-33.
Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, et al.; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA. 2007;297:1319-31.
Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, Piña IL, et al. Characterization and prognostic value of persistent hyponatraemia in patients with severe heart failure in the ESCAPE trial. Arch Intern Med. 2007;167:1998-2005.
Eng SH, Jaarsma T, Lupón J, González B, Ehrlin J, Díaz V, et al. Thirst and factors associated with frequent thirst in patients with heart failure in Spain. Heart Lung. 2021;50:86-91.
Waldréus N, Hahn RG, Jaarsma T. Thirst in heart failure: a systematic literature review. Eur J Heart Fail. 2013;15:141-9.
Verbrugge FH, Grodin JL, Mullens W, Taylor DO, Starling RC, Tang WH. Transient hyponatremia during hospitalization for acute heart failure. Am J Med. 2016;129:620-7.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al.; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022;24:4-131.
Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, et al.; Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016;18:613-25.
Maggioni AP, Anker SD, Dahlström U, Filippatos G, Ponikowski P, Zannad F, et al.; Heart Failure Association of the ESC. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2013;15:1173-84.
Kapłon-Cieślicka A, Benson L, Chioncel O, Crespo-Leiro MG, Coats AJS, Anker SD, et al.; Heart Failure Association (HFA) of the European Society of Cardiology (ESC) and the ESC Heart Failure Long-Term Registry Investigators. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry. Eur J Heart Fail. 2022;24:335-50.
van Buuren S, Groothuis-Oudshoorn CG. MICE: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1-67.
Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail. 2012;5:54-62.
Kristjánsdóttir I, Thorvaldsen T, Lund LH. Congestion and diuretic resistance in acute or worsening heart failure. Card Fail Rev. 2020;6:e25.
Verbrugge FH, Steels P, Grieten L, Nijst P, Tang WH, Mullens W. Hyponatraemia in acute decompensated heart failure: depletion versus dilution. J Am Coll Cardiol. 2015;65:480-92.
Alukal JJ, John S, Thuluvath PJ. Hyponatraemia in cirrhosis: an update. Am J Gastroenterol. 2020;115:1775-85.
John S, Thuluvath PJ. Hyponatraemia in cirrhosis: pathophysiology and management. World J Gastroenterol. 2015;21:3197-205.
Lim LM, Tsai NC, Lin MY, Hwang DY, Lin HY, Lee JJ, et al. Hyponatraemia is associated with fluid imbalance and adverse renal outcome in chronic kidney disease patients treated with diuretics. Sci Rep. 2016;6:36817.
Wang J, Zhou W, Yin X. Improvement of hyponatraemia is associated with lower mortality risk in patients with acute decompensated heart failure: a meta-analysis of cohort studies. Heart Fail Rev. 2019;24:209-17.
Xia YM, Wang S, Wu WD, Liang JF. Association between serum sodium level trajectories and survival in patients with heart failure. ESC Heart Fail. 2023;10:255-63.
Brisco-Bacik MA, Ter Maaten JM, Houser SR, Vedage NA, Rao V, Ahmad T, et al. Outcomes associated with a strategy of adjuvant metolazone or high-dose loop diuretics in acute decompensated heart failure: a propensity analysis. J Am Heart Assoc. 2018;7:e009149.
Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, et al.; NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364:797-805.
Mapelli M, Salvioni E, de Martino F, Mattavelli I, Bonomi A, Sassi V, et al. Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction. J Cardiovasc Med (Hagerstown). 2020;21:882-8.
Ter Maaten JM, Damman K, Hanberg JS, Givertz MM, Metra M, O'Connor CM, et al. Hypochloremia, diuretic resistance, and outcome in patients with acute heart failure. Circ Heart Fail. 2016;9:e003109.

Auteurs

Agnieszka Kapłon-Cieślicka (A)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Lina Benson (L)

Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Ovidiu Chioncel (O)

Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu' and University of Medicine Carol Davila, Bucharest, Romania.

Maria G Crespo-Leiro (MG)

Unidad de Insuficiencia Cardiaca y Trasplante Cardiaco, Complexo Hospitalario Universitario A Coruna (CHUAC), INIBIC, Universidad de A Coruña (UDC), CIBERCV, La Coruna, Spain.

Andrew J S Coats (AJS)

Heart Research Institute, Sydney, Australia.

Stefan D Anker (SD)

Department of Cardiology (CVK), Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin; Charité Universitätsmedizin Berlin, Berlin, Germany.

Frank Ruschitzka (F)

Department of Cardiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Camilla Hage (C)

Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Cardiology, Heart, Vascular and Neuro Theme, Karolinska University Hospital, Stockholm, Sweden.

Jarosław Drożdż (J)

Department of Cardiology, Medical University of Lodz, Lodz, Poland.

Petar Seferovic (P)

Faculty of Medicine, University of Belgrade, and Serbian Academy of Sciences and Arts, Belgrade, Serbia.

Giuseppe M C Rosano (GMC)

St George's Hospitals NHS Trust University of London, UK, and University San Raffaele and IRCCS San Raffaele, Rome, Italy.

Massimo Piepoli (M)

Clinical Cardiology, IRCCS Policlinico San Donato Milanese, Milan, Italy.

Alexandre Mebazaa (A)

Université de Paris, MASCOT, Inserm, and Department of Anesthesia, Burn and Critical Care Medicine, AP-HP, Hôpital Lariboisière, Paris, France.

Theresa McDonagh (T)

King's College Hospital, London, UK.

Mitja Lainscak (M)

Division of Cardiology, General Hospital Murska Sobota, Murska Sobota, and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Gianluigi Savarese (G)

Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Cardiology, Heart, Vascular and Neuro Theme, Karolinska University Hospital, Stockholm, Sweden.

Roberto Ferrari (R)

Centro Cardiologico Universitario di Ferrara, University of Ferrara, and Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.

Wilfried Mullens (W)

Ziekenhuis Oost-Limburg, Genk and Hasselt University, Hasselt, Belgium.

Antoni Bayes-Genis (A)

CIBER Cardiovascular, Madrid, Institut del Cor, Hospital Universitari Germans Trias i Pujol, Barcelona, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.

Aldo P Maggioni (AP)

ANMCO Research Center, Heart Care Foundation, Florence, Italy.

Lars H Lund (LH)

Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Cardiology, Heart, Vascular and Neuro Theme, Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH